A simple and robust UPLC-SRM/MS method to quantify urinary eicosanoids

Journal of Lipid Research

Volumn 53, Issue 5, 2012, Pages 1026-1036

  Sterz, Katharina ^a   Scherer, Gerhard ^a   Ecker, Josef ^a  

^a ABF Analytisch Biologisches Forschungslabor GmbH   (Germany)

Author keywords

Biomarkers; Eicosanoids; LC MS MS; Ultraperformance liquid chromatography selected reaction monitoring mass spectroscopy; Urine

Indexed keywords

11 OXOTHROMBOXANE B2; 12 HYDROXYICOSATETRAENOIC ACID; 2,3 DINOR 8 ISOPROSTAGLANDIN F1 ALPHA; 2,3 DINORTHROMBOXANE B2; 8 ISOPROSTAGLANDIN F2 ALPHA; ICOSANOID; LEUKOTRIENE E4; TETRANOR PGE M; UNCLASSIFIED DRUG;

ARTICLE; COLLISIONALLY ACTIVATED DISSOCIATION; CONTROLLED STUDY; FATTY ACID ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTERMETHOD COMPARISON; LIQUID LIQUID EXTRACTION; MASS SPECTROMETRY; NORMAL HUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROSTAGLANDIN URINE LEVEL; QUANTITATIVE ANALYSIS; REACTION TIME; SELECTED REACTION MONITORING MASS SPECTROSCOPY; SENSITIVITY ANALYSIS; SMOKING; SOLID PHASE EXTRACTION; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

ANALYTIC SAMPLE PREPARATION METHODS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EICOSANOIDS; HUMANS; INFLAMMATION MEDIATORS; REPRODUCIBILITY OF RESULTS; SMOKING; TANDEM MASS SPECTROMETRY; URINALYSIS;

EID: 84860304819     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.D023739     Document Type: Article

References (53)

1. Calder, P. C. 2009. Polyunsaturated fatty acids and inflammatory processes: new twists in an old tale. Biochimie. 91: 791-795.
2. Schmitz, G., and J. Ecker. 2008. The opposing effects of n-3 and n-6 fatty acids. Prog. Lipid Res. 47: 147-155.
3. Dennis, E. A., J. Cao, Y. H. Hsu, V. Magrioti, and G. Kokotos. 2011. Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. Chem. Rev. 111: 6130-6185.
4. Ecker, J., G. Liebisch, M. Englmaier, M. Grandl, H. Robenek, and G. Schmitz. 2010. Induction of fatty acid synthesis is a key requirement for phagocytic differentiation of human monocytes. Proc. Natl. Acad. Sci. USA. 107: 7817-7822.
5. Ecker, J., G. Liebisch, M. Grandl, and G. Schmitz. 2010. Lower SCD expression in dendritic cells compared to macrophages leads to membrane lipids with less mono-unsaturated fatty acids. Immunobiology. 215: 748-755.
6. Ecker, J., G. Liebisch, M. Scherer, and G. Schmitz. 2010. Differential effects of conjugated linoleic acid isomers on macrophage glycerophospholipid metabolism. J. Lipid Res. 51: 2686-2694.
7. Calder, P. C., R. Albers, J. M. Antoine, S. Blum, R. Bourdet-Sicard, G. A. Ferns, G. Folkerts, P. S. Friedmann, G. S. Frost, F. Guarner, et al. 2009. Inflammatory disease processes and interactions with nutrition. Br. J. Nutr. 101 (Suppl 1) : S1-S45.
8. Stanke-Labesque, F., P. Moliere, J. Bessard, M. Laville, E. Vericel, and M. Lagarde. 2008. Effect of dietary supplementation with increasing doses of docosahexaenoic acid on neutrophil lipid composition and leukotriene production in human healthy volunteers. Br. J. Nutr. 100: 829-833.
9. Smyth, E. M., T. Grosser, M. Wang, Y. Yu, and G. A. FitzGerald. 2009. Prostanoids in health and disease. J. Lipid Res. 50 (Suppl) : S423-S428.
10. Buczynski, M. W., D. S. Dumlao, and E. A. Dennis. 2009. Thematic review series: proteomics. An integrated omics analysis of eicosanoid biology. J. Lipid Res. 50: 1015-1038.
11. Murphey, L. J., M. K. Williams, S. C. Sanchez, L. M. Byrne, I. Csiki, J. A. Oates, D. H. Johnson, and J. D. Morrow. 2004. Quantification of the major urinary metabolite of PGE2 by a liquid chromatographic/mass spectrometric assay: determination of cyclooxygenase- specific PGE2 synthesis in healthy humans and those with lung cancer. Anal. Biochem. 334: 266-275. (Pubitemid 39370961)
12. Kadiiska, M. B., B. C. Gladen, D. D. Baird, D. Germolec, L. B. Graham, C. E. Parker, A. Nyska, J. T. Wachsman, B. N. Ames, S. Basu, et al. 2005. Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic. Biol. Med. 38: 698-710. (Pubitemid 40249740)
13. Morrow, J. D., T. M. Harris, and L. J. Roberts 2nd. 1990. Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids. Anal. Biochem. 184: 1-10. (Pubitemid 20029736)
14. Devaraj, S., S. V. Hirany, R. F. Burk, and I. Jialal. 2001. Divergence between LDL oxidative susceptibility and urinary F(2)-isoprostanes as measures of oxidative stress in type 2 diabetes. Clin. Chem. 47: 1974-1979. (Pubitemid 33010714)
15. Pratico, D., V, M. Y. L., Trojanowski, J. Q., Rokach, J., and Fitzgerald, G. A. 1998. Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo. FASEB J. 12: 1777-1783.
16. Davi, G., F. Chiarelli, F. Santilli, M. Pomilio, S. Vigneri, A. Falco, S. Basili, G. Ciabattoni, and C. Patrono. 2003. Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. Circulation. 107: 3199-3203. (Pubitemid 36793091)
17. Chiabrando, C., A. Valagussa, C. Rivalta, T. Durand, A. Guy, E. Zuccato, P. Villa, J. C. Rossi, and R. Fanelli. 1999. Identification and measurement of endogenous beta-oxidation metabolites of 8-epi-Prostaglandin F2alpha. J. Biol. Chem. 274: 1313-1319.
18. FitzGerald, G. A. 1991. Mechanisms of platelet activation: thromboxane A2 as an amplifying signal for other agonists. Am. J. Cardiol. 68: 11B-15B.
19. Ricciotti, E., and G. A. FitzGerald. 2011. Prostaglandins and inflammation. Arterioscler. Thromb. Vasc. Biol. 31: 986-1000.
20. Davi, G., I. Catalano, M. Averna, A. Notarbartolo, A. Strano, G. Ciabattoni, and C. Patrono. 1990. Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N. Engl. J. Med. 322: 1769-1774. (Pubitemid 20194655)
21. Murphy, R. C., and M. A. Gijon. 2007. Biosynthesis and metabolism of leukotrienes. Biochem. J. 405: 379-395. (Pubitemid 47172035)
22. Rabinovitch, N. 2007. Urinary leukotriene E4. Immunol. Allergy Clin. North Am. 27: 651-664 (vii).
23. Kishi, N., N. Mano, and N. Asakawa. 2001. Direct injection method for quantitation of endogenous leukotriene E4 in human urine by liquid chromatography/electrospray ionization tandem mass spectrometry with a column-switching technique. Anal. Sci. 17: 709-713. (Pubitemid 32612254)
24. Suzuki, N., T. Hishinuma, T. Saga, J. Sato, T. Toyota, J. Goto, and M. Mizugaki. 2003. Determination of urinary 12(S)-hydroxyeicosatetraenoic acid by liquid chromatography-tandem mass spectrometry with column-switching technique: sex difference in healthy volunteers and patients with diabetes mellitus. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 783: 383-389. (Pubitemid 35447989)
25. Gonzalez-Nunez, D., J. Claria, F. Rivera, and E. Poch. 2001. Increased levels of 12(S)-HETE in patients with essential hypertension. Hypertension. 37: 334-338. (Pubitemid 32199096)
26. Yeung, J., and M. Holinstat. 2011. 12-lipoxygenase: a potential target for novel anti-platelet therapeutics. Cardiovasc. Hematol. Agents Med. Chem. 9: 154-164.
27. Huang, R. Y., and G. G. Chen. 2011. Cigarette smoking, cyclooxygenase-2 pathway and cancer. Biochim. Biophys. Acta. 1815: 158-169.
28. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917.
29. Neale, J. R., and B. J. Dean. 2008. Liquid chromatography-tandem mass spectrometric quantification of the dehydration product of tetranor PGE-M, the major urinary metabolite of prostaglandin E(2) in human urine. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 871: 72-77.
30. Dumlao, D. S., M. W. Buczynski, P. C. Norris, R. Harkewicz, and E. A. Dennis. 2011. High-throughput lipidomic analysis of fatty acid derived eicosanoids and N-acylethanolamines. Biochim. Biophys. Acta. 1811: 724-736.
31. Dahl, J. H., and R. B. van Breemen. 2010. Rapid quantitative analysis of 8-iso-prostaglandin-F(2alpha) using liquid chromatography-tandem mass spectrometry and comparison with an enzyme immunoassay method. Anal. Biochem. 404: 211-216.
32. Masoodi, M., and A. Nicolaou. 2006. Lipidomic analysis of twentyseven prostanoids and isoprostanes by liquid chromatography/electrospray tandem mass spectrometry. Rapid Commun. Mass Spectrom. 20: 3023-3029. (Pubitemid 44569781)
33. Mesaros, C., S. H. Lee, and I. A. Blair. 2009. Targeted quantitative analysis of eicosanoid lipids in biological samples using liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877: 2736-2745.
34. Zhang, Y., G. Zhang, P. A. Clarke, J. T. Huang, E. Takahashi, D. Muirhead, R. C. Steenwyk, and Z. Lin. 2011. Simultaneous and high-throughput quantitation of urinary tetranor PGDM and tetranor PGEM by online SPE-LC-MS/MS as inflammatory biomarkers. J. Mass Spectrom. 46: 705-711.
35. Lynch, C. M., R. O'Kelly, B. Stuart, A. Treumann, R. Conroy, and C. L. Regan. 2011. The role of thromboxane A(2) in the pathogenesis of intrauterine growth restriction associated with maternal smoking in pregnancy. Prostaglandins Other Lipid Mediat. 95: 63-67.
36. Yan, W., G. D. Byrd, and M. W. Ogden. 2007. Quantitation of isoprostane isomers in human urine from smokers and nonsmokers by LC-MS/MS. J. Lipid Res. 48: 1607-1617. (Pubitemid 47312022)
37. Li, H., J. A. Lawson, M. Reilly, M. Adiyaman, S. W. Hwang, J. Rokach, and G. A. FitzGerald. 1999. Quantitative high performance liquid chromatography/tandem mass spectrometric analysis of the four classes of F(2)-isoprostanes in human urine. Proc. Natl. Acad. Sci. USA. 96: 13381-13386.
38. Taylor, A. W., R. S. Bruno, and M. G. Traber. 2008. Women and smokers have elevated urinary F(2)-isoprostane metabolites: a novel extraction and LC-MS methodology. Lipids. 43: 925-936.
39. Yue, H., S. A. Jansen, K. I. Strauss, M. R. Borenstein, M. F. Barbe, L. J. Rossi, and E. Murphy. 2007. A liquid chromatography/mass spectrometric method for simultaneous analysis of arachidonic acid and its endogenous eicosanoid metabolites prostaglandins, dihydroxyeicosatrienoic acids, hydroxyeicosatetraenoic acids, and epoxyeicosatrienoic acids in rat brain tissue. J. Pharm. Biomed. Anal. 43: 1122-1134. (Pubitemid 46185820)
40. Liebisch, G., B. Lieser, J. Rathenberg, W. Drobnik, and G. Schmitz. 2004. High-throughput quantification of phosphatidylcholine and sphingomyelin by electrospray ionization tandem mass spectrometry coupled with isotope correction algorithm. Biochim. Biophys. Acta. 1686: 108-117. (Pubitemid 39446883)
41. Zhou, Y., Z. X. Wang, M. P. Tang, C. J. Yao, W. J. Xu, L. Y. Wang, and Z. D. Qiao. 2010. Nicotine induces cyclooxygenase-2 and prostaglandin E(2) expression in human umbilical vein endothelial cells. Int. Immunopharmacol. 10: 461-466.
42. Armstrong, M., A. H. Liu, R. Harbeck, R. Reisdorph, N. Rabinovitch, and N. Reisdorph. 2009. Leukotriene-E4 in human urine: comparison of on-line purification and liquid chromatography-tandem mass spectrometry to affinity purification followed by enzyme immunoassay. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877: 3169-3174.
43. Murphy, R. C., R. M. Barkley, K. Zemski Berry, J. Hankin, K. Harrison, C. Johnson, J. Krank, A. McAnoy, C. Uhlson, and S. Zarini. 2005. Electrospray ionization and tandem mass spectrometry of eicosanoids. Anal. Biochem. 346: 1-42. (Pubitemid 41456623)
44. Martin-Venegas, R., R. Casillas, O. Jauregui, and J. J. Moreno. 2011. Rapid simultaneous analysis of cyclooxygenase, lipoxygenase and cytochrome P-450 metabolites of arachidonic and linoleic acids using high performance liquid chromatography/mass spectrometry in tandem mode. J. Pharm. Biomed. Anal. 56: 976-982.
45. Bayer, M., A. Mosandl, and D. Thaci. 2005. Improved enantioselective analysis of polyunsaturated hydroxy fatty acids in psoriatic skin scales using high-performance liquid chromatography. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 819: 323-328. (Pubitemid 40521968)
46. US Department of Health and Human Services (US DHHS). F. a. D. A. F., Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM) 2001. Guidance for industry: bioanalytical method validation. Accessed February 5, 2011, at http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM070107.pdf.
47. McAdam, B. F., D. Byrne, J. D. Morrow, and J. A. Oates. 2005. Contribution of cyclooxygenase-2 to elevated biosynthesis of thromboxane A2 and prostacyclin in cigarette smokers. Circulation. 112: 1024-1029. (Pubitemid 41170271)
48. Morrow, J. D. 2005. Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans. Arterioscler. Thromb. Vasc. Biol. 25: 279-286. (Pubitemid 40189146)
49. Miller, R. C., E. Brindle, D. J. Holman, J. Shofer, N. A. Klein, M. R. Soules, and K. A. O'Connor. 2004. Comparison of specific gravity and creatinine for normalizing urinary reproductive hormone concentrations. Clin. Chem. 50: 924-932. (Pubitemid 38543672)
50. Warrack, B. M., S. Hnatyshyn, K. H. Ott, M. D. Reily, M. Sanders, H. Zhang, and D. M. Drexler. 2009. Normalization strategies for metabonomic analysis of urine samples. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877: 547-552.
51. Gross, N. D., J. O. Boyle, J. D. Morrow, M. K. Williams, C. S. Moskowitz, K. Subbaramaiah, A. J. Dannenberg, and A. J. Duffield-Lillico. 2005. Levels of prostaglandin E metabolite, the major urinary metabolite of prostaglandin E2, are increased in smokers. Clin. Cancer Res. 11: 6087-6093. (Pubitemid 41170341)
52. Ikonomidis, I., J. Lekakis, G. Vamvakou, F. Andreotti, and P. Nihoyannopoulos. 2005. Cigarette smoking is associated with increased circulating proinflammatory and procoagulant markers in patients with chronic coronary artery disease: effects of aspirin treatment. Am. Heart J. 149: 832-839. (Pubitemid 40718878)
53. Duffield-Lillico, A. J., J. O. Boyle, X. K. Zhou, A. Ghosh, G. S. Butala, K. Subbaramaiah, R. A. Newman, J. D. Morrow, G. L. Milne, and A. J. Dannenberg. 2009. Levels of prostaglandin E metabolite and leukotriene E(4) are increased in the urine of smokers: evidence that celecoxib shunts arachidonic acid into the 5-lipoxygenase pathway. Cancer Prev. Res. 2: 322-329.